• Reference Citation Analysis
  • v
  • v
  • Find an Article
Download
Number Select Citation Analysis
1 Zheng A, Bilbao M, Sookram J, Linden KM, Morgan AB, Ostrovsky O. Epigenetic drugs induce the potency of classic chemotherapy, suppress post-treatment re-growth of breast cancer, but preserve the wound healing ability of stem cells. Cancer Biol Ther 2022;23:254-64. [PMID: 35389825 DOI: 10.1080/15384047.2022.2052540] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
2 Meliani M, Nikolić V. Analysis of General Shape Optimization Problems in Nonlinear Acoustics. APPL MATH OPT 2022;86. [DOI: 10.1007/s00245-022-09906-8] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
3 Takeda Y, Kusaba Y, Tsukita Y, Uemura Y, Miyauchi E, Yamamoto T, Mayahara H, Hata A, Nakayama H, Tanaka S, Uchida J, Usui K, Toyoda T, Tamiya M, Morimoto M, Oya Y, Kodaira T, Jingu K, Sugiura H. The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter retrospective cohort study. Clin Transl Radiat Oncol 2022;37:57-63. [DOI: 10.1016/j.ctro.2022.08.010] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
4 Rampogu S, Balasubramaniyam T, Lee J. Phytotherapeutic applications of alkaloids in treating breast cancer. Biomed Pharmacother 2022;155:113760. [DOI: 10.1016/j.biopha.2022.113760] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
5 Wu Y, Xie CB, He YH, Ke D, Huang Q, Zhao KF, Shi RS. Three-in-one incidence of hepatocellular carcinoma, cholangiocellular carcinoma, and neuroendocrine carcinoma: A case report. World J Clin Cases 2022; 10(29): 10575-10582 [DOI: 10.12998/wjcc.v10.i29.10575] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
6 Moritsch S, Mödl B, Scharf I, Janker L, Zwolanek D, Timelthaler G, Casanova E, Sibilia M, Mohr T, Kenner L, Herndler-Brandstetter D, Gerner C, Müller M, Strobl B, Eferl R. Tyk2 is a tumor suppressor in colorectal cancer. Oncoimmunology 2022;11:2127271. [PMID: 36185806 DOI: 10.1080/2162402X.2022.2127271] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
7 Anaikutti P, Selvaraj M, Prabhakaran J, Pooventhiran T, Jeyakumar TC, Thomas R, Makam P. Indolyl-4H-chromenes: Multicomponent one-pot green synthesis, in vitro and in silico, anticancer and antioxidant studies. J Mol Struct 2022;1266:133464. [DOI: 10.1016/j.molstruc.2022.133464] [Cited by in Crossref: 3] [Cited by in RCA: 2] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
8 Yoo J, Kim HJ, Kim SM, Park HH. Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid cancer. Eur Thyroid J 2022;11:e220087. [PMID: 35900775 DOI: 10.1530/ETJ-22-0087] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
9 Zhan H, Sun C, Luo T, Xi G, Guo Y, Xu M, Chen Y, Zhuo S. Identification of the Tumor Boundary of Hilar Cholangiocarcinoma Based on Multiphoton Microscopy. IEEE Photonics J 2022;14:1-7. [DOI: 10.1109/jphot.2022.3203511] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
10 Okunade KS, Adejimi AA, John-Olabode SO, Oshodi YA, Oluwole AA. An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation. Healthc Policy 2022;15:1823-30. [PMID: 36176779 DOI: 10.2147/RMHP.S296914] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
11 Sachi Das S, Singh SK, Verma PRP, Gahtori R, Sibuh BZ, Kesari KK, Jha NK, Dhanasekaran S, Thakur VK, Wong LS, Djearamane S, Gupta PK. Polyester nanomedicines targeting inflammatory signaling pathways for cancer therapy. Biomed Pharmacother 2022;154:113654. [PMID: 36067568 DOI: 10.1016/j.biopha.2022.113654] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
12 Ma SJ, Yu H, Khan M, Yu B, Santhosh S, Chatterjee U, Gill J, Iovoli A, Farrugia M, Wooten K, Gupta V, McSpadden R, Kuriakose MA, Markiewicz MR, Al-Afif A, Hicks WL Jr, Platek ME, Seshadri M, Ray AD, Repasky E, Singh AK. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation. Oral Oncol 2022;133:106054. [PMID: 35933937 DOI: 10.1016/j.oraloncology.2022.106054] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
13 Schmidt M, Benzler K, Lauer UM, Zender L, Hinterleitner C, Hinterleitner M. Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients. J Clin Med 2022;11:5798. [DOI: 10.3390/jcm11195798] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
14 Cheng T, Chen J, Ying P, Wei H, Shu H, Kang M, Zou J, Ling Q, Liao X, Wang Y, Shao Y. Clinical risk factors of carbohydrate antigen-125, cytokeratin fragment 19, and neuron-specific enolase in liver metastases from elderly lung cancer patients. Front Genet 2022;13:1013253. [DOI: 10.3389/fgene.2022.1013253] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
15 Wen A, Wang X, Wang B, Yan C, Luo J, Wang P, Li J. Comparative Analysis of 60Co and 192Ir Sources in High Dose Rate Brachytherapy for Cervical Cancer. Cancers (Basel) 2022;14:4749. [DOI: 10.3390/cancers14194749] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
16 Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D, Erdmann F, Karow A, Metzler M, Suttorp M. Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia. Front Oncol 2022;12:963223. [DOI: 10.3389/fonc.2022.963223] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
17 Renteria M, Belkin O, Jang D, Aickareth J, Bhalli M, Zhang J. CmPn signaling networks in the tumorigenesis of breast cancer. Front Endocrinol (Lausanne) 2022;13:1013892. [DOI: 10.3389/fendo.2022.1013892] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
18 Zhu Y, Xiao T, He Y, Hong X, Zhou T, Da M, Ge S, Xie D, Wang Z. Application of near-infrared fluorescence imaging in lingual lymph node screening and drainage pattern observation for tongue cancer. Front Cell Dev Biol 2022;10:986575. [DOI: 10.3389/fcell.2022.986575] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
19 Gómez-Barea M, García-Sánchez T, Ivorra A. A computational comparison of radiofrequency and pulsed field ablation in terms of lesion morphology in the cardiac chamber. Sci Rep 2022;12:16144. [PMID: 36167959 DOI: 10.1038/s41598-022-20212-9] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
20 Fredén E, Tilly D, Ahnesjö A. Adaptive dose painting for prostate cancer. Front Oncol 2022;12:973067. [DOI: 10.3389/fonc.2022.973067] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
21 Alberti A, Smussi D, Zamparini M, Turla A, Laini L, Marchiselli C, Grisanti S, Bossi P, Berruti A. Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases. Front Oncol 2022;12:997009. [DOI: 10.3389/fonc.2022.997009] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
22 Becherini C, Banini M, Desideri I, Salvestrini V, Caprara L, Scotti V, Ganovelli M, Morelli I, Romei A, Livi L, Bonomo P. Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma. J Geriatr Oncol 2022:S1879-4068(22)00228-4. [PMID: 36175350 DOI: 10.1016/j.jgo.2022.09.009] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
23 Baranovicova E, Racay P, Zubor P, Smolar M, Kudelova E, Halasova E, Dvorska D, Dankova Z. Circulating metabolites in the early stage of breast cancer were not related to cancer stage or subtypes but associated with ki67 level. Promising statistical discrimination from controls. Mol Cell Probes 2022;:101862. [PMID: 36162596 DOI: 10.1016/j.mcp.2022.101862] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
24 Wu Y, Wang Z, Yu S, Liu D, Sun L. LncmiRHG-MIR100HG: A new budding star in cancer. Front Oncol 2022;12:997532. [DOI: 10.3389/fonc.2022.997532] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
25 Kudo-saito C, Boku N, Hirano H, Shoji H. Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer. Front Immunol 2022;13:1009701. [DOI: 10.3389/fimmu.2022.1009701] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
26 Abedi-gaballu F, Kamal Kazemi E, Salehzadeh SA, Mansoori B, Eslami F, Emami A, Dehghan G, Baradaran B, Mansoori B, Cho WC. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs. Cells 2022;11:2973. [DOI: 10.3390/cells11192973] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
27 Przystupski D, Ussowicz M. Landscape of Cellular Bioeffects Triggered by Ultrasound-Induced Sonoporation. Int J Mol Sci 2022;23:11222. [DOI: 10.3390/ijms231911222] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
28 Kim E, Kum J, Lee SH, Kim H. Development of a wireless ultrasonic brain stimulation system for concurrent bilateral neuromodulation in freely moving rodents. Front Neurosci 2022;16:1011699. [DOI: 10.3389/fnins.2022.1011699] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
29 Kripa E, Rizzo V, Galati F, Moffa G, Cicciarelli F, Catalano C, Pediconi F. Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesity. Front Oncol 2022;12:987012. [DOI: 10.3389/fonc.2022.987012] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
30 Osborne LM, Payne JL, Sherer ML, Sabunciyan S. Altered extracellular mRNA communication in postpartum depression is associated with decreased autophagy. Mol Psychiatry 2022. [PMID: 36138128 DOI: 10.1038/s41380-022-01794-2] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
31 Goel S, Tan AR, Rugo HS, Aftimos P, Andrić Z, Beelen A, Zhang J, Yi JS, Malik R, O'Shaughnessy J. Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2. Future Oncol 2022. [PMID: 36135712 DOI: 10.2217/fon-2022-0773] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
32 Fitriana N, Rifa’i M, Masruri, Wicaksono ST, Nashi Widodo. Anticancer effects of Curcuma zedoaria (Berg.) Roscoe ethanol extract on a human breast cancer cell line. CHEM PAP. [DOI: 10.1007/s11696-022-02482-9] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
33 Candido S, Tomasello B, Lavoro A, Falzone L, Gattuso G, Russo A, Paratore S, Mccubrey JA, Libra M. Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment. Front Cell Dev Biol 2022;10:945586. [DOI: 10.3389/fcell.2022.945586] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
34 Rączkowski Ł, Paśnik I, Kukiełka M, Nicoś M, Budzinska MA, Kucharczyk T, Szumiło J, Krawczyk P, Crosetto N, Szczurek E. Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer. BMC Cancer 2022;22:1001. [PMID: 36131239 DOI: 10.1186/s12885-022-10081-w] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
35 Wang Y, Minden A. Current Molecular Combination Therapies Used for the Treatment of Breast Cancer. Int J Mol Sci 2022;23:11046. [DOI: 10.3390/ijms231911046] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
36 Chiara LD, Barcia-castro L, Gallardo-gómez M, Cadena MPDL, Martínez-zorzano VS, Rodríguez-berrocal FJ, Bujanda L, Etxart A, Castells A, Balaguer F, Jover R, Cubiella J, Cordero OJ. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs. Cancers (Basel) 2022;14:4563. [DOI: 10.3390/cancers14194563] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
37 Goel V, Sharma D, Sharma A, Mallick S. A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer. Radiother Oncol 2022;176:59-67. [PMID: 36184999 DOI: 10.1016/j.radonc.2022.09.007] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
38 Diéguez-Martínez N, Espinosa-Gil S, Yoldi G, Megías-Roda E, Bolinaga-Ayala I, Viñas-Casas M, Gorgisen G, Domingo-Ortí I, Pérez-Montoyo H, Bayascas JR, Colas E, Dolcet X, Lizcano JM. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival. Cell Mol Life Sci 2022;79:524. [PMID: 36123565 DOI: 10.1007/s00018-022-04541-6] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
39 Gámez-Chiachio M, Sarrió D, Moreno-Bueno G. Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs. Cancers (Basel) 2022;14:4543. [PMID: 36139701 DOI: 10.3390/cancers14184543] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
40 Brindisi M, Curcio M, Frattaruolo L, Cirillo G, Leggio A, Rago V, Nicoletta FP, Cappello AR, Iemma F. CD44-targeted nanoparticles with GSH-responsive activity as powerful therapeutic agents against breast cancer. Int J Biol Macromol 2022;221:1491-503. [PMID: 36130642 DOI: 10.1016/j.ijbiomac.2022.09.157] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
41 Rajput K, Ansari MN, Jha SK, Pani T, Medatwal N, Chattopadhyay S, Bajaj A, Dasgupta U. Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells. Cancers (Basel) 2022;14:4496. [PMID: 36139656 DOI: 10.3390/cancers14184496] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
42 Conde-estévez D, Henríquez I, Muñoz-rodríguez J, Rodriguez-vida A. Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions. Expert Opin Drug Metab Toxicol. [DOI: 10.1080/17425255.2022.2122812] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
43 Habil MR, Salazar-gonzález RA, Doll MA, Hein DW. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes. Arch Toxicol. [DOI: 10.1007/s00204-022-03381-4] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
44 Takagi T, Sugimoto M, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Nakamura J, Takasumi M, Hashimoto M, Kato T, Kobashi R, Yanagita T, Hashimoto Y, Marubashi S, Hikichi T, Ohira H. Screening for hilar biliary invasion in ampullary cancer patients. World J Gastrointest Endosc 2022; 14(9): 536-546 [DOI: 10.4253/wjge.v14.i9.536] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
45 Fraile-martinez O, Alvarez-mon MA, Garcia-montero C, Pekarek L, Guijarro LG, Lahera G, Saez MA, Monserrat J, Motogo D, Quintero J, Alvarez-mon M, Ortega MA. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine. Front Oncol 2022;12:956923. [DOI: 10.3389/fonc.2022.956923] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
46 Valenzuela G, Burotto M, Marcelain K, González-Montero J. Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer. World J Gastrointest Oncol 2022; 14(9): 1654-1664 [DOI: 10.4251/wjgo.v14.i9.1654] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
47 Dai L, Cui H, Bao Y, Hu L, Zhou Z, Wang M, Lin S, Wu H, Kang H, Ma X. The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer. Cancer Med. [DOI: 10.1002/cam4.5166] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
48 Famurewa AC, Mukherjee AG, Wanjari UR, Sukumar A, Murali R, Renu K, Vellingiri B, Dey A, Valsala Gopalakrishnan A. Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs. Life Sci 2022;305:120789. [PMID: 35817170 DOI: 10.1016/j.lfs.2022.120789] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]
49 Farjadian F, Ghasemi S, Akbarian M, Hoseini-ghahfarokhi M, Moghoofei M, Doroudian M. Physically stimulus-responsive nanoparticles for therapy and diagnosis. Front Chem 2022;10:952675. [DOI: 10.3389/fchem.2022.952675] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
50 Ambur Sankaranarayana R, Florea A, Allekotte S, Vogg ATJ, Maurer J, Schäfer L, Bolm C, Terhorst S, Classen A, Bauwens M, Morgenroth A, Mottaghy FM. PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer. EJNMMI Res 2022;12. [DOI: 10.1186/s13550-022-00932-9] [Cited by in Crossref: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text]  Open
PrevPage 1 of 146 12345145146Next
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA